Suppr超能文献

与半枝莲多糖偶联的硒纳米颗粒:合成、优化、结构表征及体内外抗肝癌活性评价

Selenium nanoparticles conjugated with Scutellaris barbata D. Don polysaccharides: Synthesis, optimization, structural characterization and evaluation of anti-hepatoma activity in vitro and in vivo.

作者信息

Shan Rong, Xu Xiaoyi, Yin Yongkui, Liang Jun, Yuan Hui, Gao Xiaoyan, Zhao Qingxue, Song Gaochen

机构信息

College of Basic Medicine, Mudanjiang Medical University, Mudanjiang 157011, China.

The First Clinical College of Medicine, Mudanjiang Medical University, Mudanjiang 157011, China.

出版信息

Int J Biol Macromol. 2025 Aug;319(Pt 2):145196. doi: 10.1016/j.ijbiomac.2025.145196. Epub 2025 Jun 16.

Abstract

Scutellaria barbata D. Don polysaccharide (SBP), a bioactive herbal component with well-documented antitumor properties, was conjugated with selenium nanoparticles (SeNPs), which are recognized for their high bioavailability and low toxicity. In this study, SBP was conjugated with SeNPs to synthesize SBP selenium nanoparticles (SBP-Se), and response surface methodology (RSM) was employed to optimize the synthesis conditions of SBP-Se. The structural properties of SBP-Se were characterized by multiple analytical techniques, and its anti-hepatoma activity was evaluated both in vitro and in vivo. The results demonstrated that SBP is primarily bound to SeNPs through the adsorption of phenolic hydroxyl groups, forming stable SBP-Se containing elemental selenium. Cell-based assays revealed that SBP-Se exhibited significantly enhanced antiproliferative effects against HepG2 cells than SBP or SeNPs alone. In a BALB/c mouse model, SBP-Se significantly inhibited HepG2 cell proliferation and migration. Furthermore, SBP-Se was found to inhibit mTOR-PI3K-Akt-mediated proliferation in HepG2 cells. These findings suggest that SBP-Se is a promising candidate for the development of antitumor pharmaceuticals, providing a theoretical foundation for the design of novel selenium-based structures and elucidating their anti-liver cancer mechanisms.

摘要

半枝莲多糖(SBP)是一种具有抗肿瘤特性的生物活性草药成分,与具有高生物利用度和低毒性的硒纳米颗粒(SeNPs)结合。在本研究中,将SBP与SeNPs结合以合成SBP硒纳米颗粒(SBP-Se),并采用响应面法(RSM)优化SBP-Se的合成条件。通过多种分析技术对SBP-Se的结构性质进行了表征,并在体外和体内评估了其抗肝癌活性。结果表明,SBP主要通过酚羟基的吸附与SeNPs结合,形成含有元素硒的稳定SBP-Se。细胞实验表明,SBP-Se对HepG2细胞的抗增殖作用明显强于单独的SBP或SeNPs。在BALB/c小鼠模型中,SBP-Se显著抑制HepG2细胞的增殖和迁移。此外,发现SBP-Se抑制HepG2细胞中mTOR-PI3K-Akt介导的增殖。这些发现表明,SBP-Se是开发抗肿瘤药物的有希望的候选物,为新型硒基结构的设计及其抗肝癌机制的阐明提供了理论基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验